Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma
about
Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinomaEmerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)Biomarkers in pancreatic adenocarcinoma: current perspectivesClinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis.Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer.Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse modelsPrognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer.Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinomaPrognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based ChemotherapyPrognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancer.Aberrant glycosylation as biomarker for cancer: focus on CD43.Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinomaPrognostic factors related with survival in patients with pancreatic adenocarcinomaBiomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures.Metastatic pancreatic adenocarcinoma presented as back pain in pregnancy: case report and review of literature.Primary analysis for clinical efficacy of immunotherapy in patients with pancreatic cancer.Implication of suspicious cytology in endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer.Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis.Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale".Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
P2860
Q26739910-87F87886-71C1-4A4A-8416-864FAB3CC158Q26796523-D33246FA-E29A-42D0-96C5-CE1105697325Q28072309-934A53C4-E507-4D48-BDB8-65A0C41F452CQ30235405-D061B8D5-1C43-440D-B4D9-BB1CCC68CB4AQ35138972-00B7C73B-B0A4-488E-838F-EC1E0E1BE332Q36310097-B295ADD8-0A45-4560-BBBD-6662FD0EF531Q36403838-2BCAD9FE-0843-411A-BB6D-8880330E421FQ37109728-08AA4387-5AAB-4024-BCD0-14CEC14654BAQ37259570-6BBB580D-3E43-4EE6-9D0C-30478D22B37FQ37327988-C5C2C866-C514-433B-BE48-819D80D3369AQ37367435-76443C32-60B8-42B8-89D7-435B960E45F0Q37367504-750EA109-B392-406B-99A8-21CF5E4E3A53Q37525286-B7823F2E-F24D-4552-AA77-FCAC603D4C89Q37618865-03912E9B-E615-495D-A5C8-D028D5152F1DQ37717226-05FC3577-AEE3-452C-96A9-BEC52FA28148Q38242807-E969B072-D1B9-497A-B076-EA41AD7CB274Q38434946-DFF6BDE5-4266-4D20-838B-952AC8469F9EQ38525538-773A125F-1D0F-4D4D-982D-23C6B1F7E482Q38632737-5DEC8DB5-5DF4-4780-960F-42573E09EF2DQ41598122-21F2F0EC-1DA2-43DA-9EB3-03933D99AA73Q41908975-D06D9576-17ED-410C-BF4F-55ED2EA4421FQ43781103-43FED00F-5850-46D0-9C50-77BF2B083C96Q50579768-103971A5-FCD1-4DFE-9890-097AC61D67CCQ58608661-EF575EF8-74D2-4326-8E24-C8A85CF9C430
P2860
Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma
@ast
Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma
@en
type
label
Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma
@ast
Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma
@en
prefLabel
Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma
@ast
Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma
@en
P2093
P2860
P1476
Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma
@en
P2093
Jae Bock Chung
Jeong Youp Park
Kyong Joo Lee
Moon Jae Chung
Seung Woo Park
Seung Woo Yi
Si Young Song
P2860
P304
P356
10.3349/YMJ.2013.54.3.643
P577
2013-05-01T00:00:00Z